Coloplast A/S (CLPBY)

Market Cap	27.64B
Revenue (ttm)	4.04B
Net Income (ttm)	755.59M
Shares Out	n/a
EPS (ttm)	3.36
PE Ratio	n/a
Forward PE	n/a
Dividend	0.20 (1.56%)
Ex-Dividend Date	Dec 9, 2024

Volume	16,198
Open	12.44
Previous Close	12.60
Day's Range	12.32 - 12.47
52-Week Range	10.69 - 14.34
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the B...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1954
• Employees: 16,639
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLPBY

Financial Performance

In 2024, Coloplast's revenue was 27.03 billion, an increase of 10.33% compared to the previous year's 24.50 billion. Earnings were 5.05 billion, an increase of 5.62%.

Financial numbers in DKK